DK168333B1 - Analogifremgangsmåde til fremstilling af anthracen-9,10-bis-carbonylhydrazoner og derivater eller salte deraf - Google Patents

Analogifremgangsmåde til fremstilling af anthracen-9,10-bis-carbonylhydrazoner og derivater eller salte deraf Download PDF

Info

Publication number
DK168333B1
DK168333B1 DK529778A DK529778A DK168333B1 DK 168333 B1 DK168333 B1 DK 168333B1 DK 529778 A DK529778 A DK 529778A DK 529778 A DK529778 A DK 529778A DK 168333 B1 DK168333 B1 DK 168333B1
Authority
DK
Denmark
Prior art keywords
bis
hydrogen
process according
analogous process
anthracenedicarboxaldehyde
Prior art date
Application number
DK529778A
Other languages
Danish (da)
English (en)
Other versions
DK529778A (da
Inventor
Keith Chadwick Murdock
Frederick Emil Durr
Ralph Grassing Child
Jr Stanley Albert Lang
Ving Jick Lee
Yani-I Lin
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DK529778A publication Critical patent/DK529778A/da
Application granted granted Critical
Publication of DK168333B1 publication Critical patent/DK168333B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72Hydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77Hydrazine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/52Nitrogen atoms not forming part of a nitro radical with hetero atoms directly attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12Nitrogen atoms not forming part of a nitro radical
    • C07D239/18Nitrogen atoms not forming part of a nitro radical with hetero atoms attached to said nitrogen atoms, except nitro radicals, e.g. hydrazine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/04Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24Anthracenes; Hydrogenated anthracenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
DK529778A 1977-11-28 1978-11-27 Analogifremgangsmåde til fremstilling af anthracen-9,10-bis-carbonylhydrazoner og derivater eller salte deraf DK168333B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85514677A 1977-11-28 1977-11-28
US85514677 1977-11-28

Publications (2)

Publication Number Publication Date
DK529778A DK529778A (da) 1979-05-29
DK168333B1 true DK168333B1 (da) 1994-03-14

Family

ID=25320461

Family Applications (1)

Application Number Title Priority Date Filing Date
DK529778A DK168333B1 (da) 1977-11-28 1978-11-27 Analogifremgangsmåde til fremstilling af anthracen-9,10-bis-carbonylhydrazoner og derivater eller salte deraf

Country Status (13)

Country Link
JP (1) JPS5488251A (hu)
AU (1) AU524932B2 (hu)
BE (1) BE872309A (hu)
CA (1) CA1117535A (hu)
DK (1) DK168333B1 (hu)
GR (1) GR69988B (hu)
GT (1) GT197855057A (hu)
HU (1) HU179661B (hu)
IL (1) IL55853A (hu)
PL (1) PL116499B1 (hu)
PT (1) PT68805A (hu)
SU (1) SU1131867A1 (hu)
ZA (1) ZA786160B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4564786B2 (ja) * 2004-06-07 2010-10-20 株式会社日本ファインケム 1−置換―1―アミノグアニジン又はその塩、及びこれらの製造方法
CA2938626A1 (en) * 2013-07-26 2015-01-29 John Rothman Compositions to improve the therapeutic benefit of bisantrene

Also Published As

Publication number Publication date
HU179661B (en) 1982-11-29
IL55853A (en) 1984-06-29
GR69988B (hu) 1982-07-23
SU1131867A1 (ru) 1984-12-30
ZA786160B (en) 1980-06-25
PT68805A (en) 1978-12-01
JPS6346064B2 (hu) 1988-09-13
CA1117535A (en) 1982-02-02
JPS5488251A (en) 1979-07-13
GT197855057A (es) 1980-05-20
PL211284A1 (hu) 1980-02-11
PL116499B1 (en) 1981-06-30
IL55853A0 (en) 1979-01-31
AU4201078A (en) 1979-06-07
BE872309A (fr) 1979-05-28
DK529778A (da) 1979-05-29
AU524932B2 (en) 1982-10-14

Similar Documents

Publication Publication Date Title
Murdock et al. Antitumor agents. II. Bis (guanylhydrazones) of anthracene-9, 10-dicarboxaldehydes
GB2094299A (en) Oxazolidines
EP3297640A1 (en) Pharmaceutical co-crystal composition and use thereof
EP0047536B1 (en) Substituted propylamines
NZ333520A (en) Substituted aminoguanidine derivatives and their use as inhibitors of sphingomyelinase
WO2006098355A1 (ja) 抗癌性を示す化合物およびその中間体ならびにそれらの製造方法
KR840001965B1 (ko) 안트라센-9,10-비스-카르보닐-히드라존 유도체 제조방법
IE44904B1 (en) Aminophosphonous acids and processes for their preparation
US4125607A (en) Daunosaminyl anthracyclinones and their use
SE445996B (sv) Nya atrakinonderivat
DK168333B1 (da) Analogifremgangsmåde til fremstilling af anthracen-9,10-bis-carbonylhydrazoner og derivater eller salte deraf
Wubbels et al. Regioselectivity of photochemical and thermal Smiles rearrangements and related reactions of. beta.-(nitrophenoxy) methylamines
WO2011137739A1 (zh) N-烷基取代反式1,2-环己二胺为配体的铂(ⅱ)配合物及其制备方法
JPS6344577A (ja) ピリミジン誘導体
FI71726B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara anracen-9,10-bis-karbonylderivat
US9328128B2 (en) Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport
US4533672A (en) Amino, cyano phenylthio or phenoxyl indole derivatives
US20050165093A1 (en) Supermolecular carboplatinum derivatives, their preparation and pharmaceutical composition containing tem as active ingredient and applications of the compositions
US4183934A (en) 4-Hydroxy-7-(substituted)phenylpteridines
US3366628A (en) 1, 2-dihydro-1-polyhydroxyalkyl-2-quinoxalinones
US4187373A (en) Novel dihydrobenzanthracene derivatives
SE436208B (sv) Sett att framstella 5-fluoro-uracilderivat
IE66828B1 (en) Thioxanthenone antitumor agents
US3066141A (en) Quinoline-type mustards and process for producing same
CA1116605A (en) Bis(2-imidazolin-2-ylhydrazone)-9,10-dihydro-9,10- anthracenedicarboxaldehydes

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired